Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05424822
Title	A Study of JNJ-80948543, a T Cell Redirecting Antibody, in Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Janssen Research & Development, LLC
Indications	chronic lymphocytic leukemia/small lymphocytic lymphoma B-cell lymphoma nodal marginal zone lymphoma lymphoplasmacytic lymphoma mantle cell lymphoma diffuse large B-cell lymphoma marginal zone lymphoma non-Hodgkin lymphoma splenic marginal zone lymphoma extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue chronic lymphocytic leukemia
Therapies	JNJ-80948543
Age Groups:	adult \| senior
Covered Countries	USA \| POL \| ISR \| FRA \| DNK \| AUS